Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORCE: Avdoralimab in COVID-19 Severe Pneumonia
NCT04371367Phase 2Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Apr 2020
- Primary completion
- Mar 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of avdoralimab in coronavirus disease 2019 (COVID-19), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Apr 2020; status: completed.
02
Drugs
avdoralimab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04371367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04371367.